Clarius Introduces Partnership with ImaCor That Powers New FDA Cleared Handheld Hemodynamic Ultrasound

News provided by

Jun 29, 2022, 08:31 ET

Now made ultra-portable with Clarius, ImaCor's Zura Handheld Hemodynamic Ultrasound^™ has received FDA clearance as the world's first handheld transesophageal echocardiography (TEE) system, enabling more clinicians to accurately determine appropriate interventions in real-time.

VANCOUVER, BC and JERICHO, N.Y., June 29, 2022 /PRNewswire/ -- Clarius Mobile Health, a leading provider of high-definition wireless ultrasound systems, and ImaCor Inc, the hemodynamic ultrasound company, today announced a partnership that enables the availability of the world's first handheld transesophageal echocardiography (TEE) system designed to manage and guide care for the most critically ill patients in the Intensive Care Unit (ICU). The Zura^™ Handheld Hemodynamic Ultrasound^™ system powered by Clarius provides an instant, clear window to directly visualize preload and contractility over time, having received clearance by the U.S. Food and Drug Administration to help clinicians make the right decisions, at the right time.

The Zura Handheld Hemodynamic UltrasoundTM system powered by Clarius provides an instant, clear window to directly visualize preload and contractility over time. It has received clearance by the U.S. Food and Drug Administration to help clinicians make the right decisions, at the right time.

"A high-risk patient's hemodynamic status changes dramatically in a matter of minutes, often while clinicians are waiting for test results they submitted 15 minutes ago," says ImaCor's Founder, Scott Roth, MD. "The Zura Handheld provides instant and accurate information to guide patient management and it's proven to save lives. More than 20,000 patients have already benefitted from our cart-based Zura system. We're excited to make this life-saving device now highly accessible to more high acuity care teams with the introduction of our handheld system, which is easier to bring to the bedside, can be used to monitor multiple patients in real-time, and takes up no floor space. We chose to partner with Clarius for our handheld solution, because it delivers the highest image quality for the best patient care."

According to Dr. Roth, hospitals will be able to purchase multiple Zura handheld systems for the cost of one cart-based system. The Zura Handheld Hemodynamic Ultrasound system is the companion device to the ClariTEE^® transesophageal echo probe. Now powered by Clarius, they comprise the first and only advanced handheld hemodynamic management platform for real-time decision making to care for the most at-risk patients. Pocket-sized, the 22-ounce handheld is a key advantage in the ICU where space is limited. The Zura Handheld operates with the Clarius Ultrasound App, which connects wirelessly to Apple and Android smart devices.

"Hemodynamic Ultrasound has played a vital role in saving lives in our most critically ill patient population," commented Dr. Dennis Ashley, Director of Trauma and Adult Critical Care at Atrium Health Navicent. "Being the first clinical team to use the new Zura Handheld aligns with our focus on bringing the latest and most innovative care options to our patients. Portability means a member of our team can have a Zura Handheld with them, ready to use and available to identify the root cause of hemodynamic compromise and successfully guide patient management right at the bedside."

"Our collaboration with ImaCor is a powerful example of how Clarius is broadening access to medical imaging and helping clinicians to provide better specialized patient care," said Clarius Founder Laurent Pelissier. "We have intentionally designed our app-based ultrasound system to push the boundaries of medical imaging. It's an honour to work with Dr. Roth and his team to make his vision for better acute care a reality, improving patient care and saving lives."

About ImaCor

ImaCor, Inc. designs, manufactures, and distributes Hemodynamic Ultrasound (hTEE), the first and only critical care solution enabling clinicians to optimize cardiac performance with continuously-available, direct cardiac visualization over time. Hemodynamic Ultrasound is the science that enables clinicians to optimize cardiac performance throughout a patient's course of treatment, allowing them to guide and assess the effectiveness of therapies, as well as make critical changes in patient management at the right time. Learn more at www.imacorinc.com.

ImaCor Media Contact:
Jenn Kujawski
Executive Vice President
Phone: +1 (516) 393-0970 ext. 402 | Direct: +1 (631) 338-0585

About Clarius Mobile Health

Clarius is on a mission to make accurate, easy-to-use, and affordable ultrasound tools available to all medical professionals in every specialty. With decades of experience in medical imaging, the team knows that great ultrasound imaging improves confidence and patient care. Today, Clarius handheld wireless ultrasound scanners connect to iOS and Android devices, delivering high-resolution ultrasound images traditionally only available with bulkier, high-end systems at a fraction of the cost.

Over two million high-definition scans have been performed using Clarius wireless handheld scanners. Clarius scanners are available in over 90 countries worldwide. Learn more at www.clarius.com.

Clarius Media Contact:
Genèse Castonguay
Marketing Vice President
Phone: +1 (866) 657-9243 ext. 221 | Direct: +1 (604) 260-7077

SOURCE Clarius Mobile Health